首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.
【24h】

The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.

机译:纤维蛋白测定比较试验(FACT):可溶性纤维蛋白测定与D-二聚体的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

Soluble fibrin (SF) is regarded as an indicator of acute fibrin formation and a precursor of fibrin thrombi. Using a set of clinical plasma samples, and fibrin derivatives, five assays for measurement of SF, including two chromogenic assays, two ELISA systems, and one latex-enhanced photometric immunoassay were compared. Correlation between SF assays was moderate (Spearman's rho values between 0.344 and 0.805). Re-calibration with serial dilutions of desAABB-fibrin monomer resulted in adjustment of the numerical scale of the assays without improving correlation. All SF assays reacted with purified crosslinked fibrin derivatives. Using clinical plasma samples, Spearman's rho of SF assays with D-dimer consensus values based upon results of 23 quantitative D-dimer assays were between 0.491 and 0.911. Although all SF assays react with desAABB-fibrin monomer complexes, SF assays are heterogeneous concerning reactivity with fibrin compounds observed in clinical plasma samples. The prospect of a common calibrator for SF assays therefore seems to be remote. Since SF assays react with crosslinked fibrin derivatives, it is not possible to clearly distinguish between acute fibrin formation, and fibrin dissolution on the basis of the results of current SF assays.
机译:可溶性血纤蛋白(SF)被认为是急性血纤蛋白形成的指标和血纤蛋白血栓的前体。使用一组临床血浆样品和血纤蛋白衍生物,比较了五种用于测量SF的测定法,包括两种显色测定法,两种ELISA系统和一种乳胶增强光度免疫测定法。 SF分析之间的相关性是中等的(Spearman的rho值在0.344和0.805之间)。用desAABB-血纤蛋白单体的系列稀释液进行重新校准导致测定数值范围的调整,而没有改善相关性。所有SF分析均与纯化的交联纤维蛋白衍生物反应。使用临床血浆样本,基于23种定量D-二聚体测定的结果,具有D-二聚体共有值的SF测定的Spearman的rho在0.491和0.911之间。尽管所有SF分析均与desAABB-纤维蛋白单体复合物反应,但SF分析在与临床血浆样品中观察到的与纤维蛋白化合物的反应性方面是异质的。因此,用于SF分析的通用校准器的前景似乎遥不可及。由于SF测定法与交联的血纤蛋白衍生物反应,因此不可能基于当前SF测定法的结果清楚地区分急性血纤蛋白形成和血纤蛋白溶解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号